Registered Nurse in Normangee, TX Accepting Medicare
1 Registered Nurse nurses found. Showing 1 - 1
 Ms. Neile Elaine Briden, APRN, FNP-C Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 910 Main Street, Normangee, TX 77871 Phone: 936-396-2806 Fax: 936-396-9000 |
News Archive
Researchers develop new technique to boost quality of brain scans
People who suffer a stroke often undergo a brain scan at the hospital, allowing doctors to determine the location and extent of the damage. Researchers who study the effects of strokes would love to be able to analyze these images, but the resolution is often too low for many analyses.
FDA warns consumers not to drink raw milk from Tucker Adkins Dairy
The FDA is working with officials in North Carolina and South Carolina to investigate an outbreak of campylobacteriosis in three people who consumed raw milk from Tucker Adkins Dairy in York, S.C. The three confirmed cases and another five probable cases are from three different households and each case reports that prior to becoming ill they consumed raw milk that was obtained from Tucker Adkins Dairy on June 14, 2011.
RegeneRx RGN-352 Phase 2 trial in acute myocardial infarction placed on clinical hold
RegeneRx Biopharmaceuticals, Inc. announced that it has received a notice from the U.S. Food and Drug Administration (FDA) indicating that, due to non-compliance with FDA's current Good Manufacturing Practice (cGMP) regulations by its contract manufacturer, the Company's Phase 2 clinical trial of RGN-352, its injectable formulation of Thymosin beta 4 for the treatment of acute myocardial infarction (AMI), has been placed on clinical hold.
Blocking molecular signaling pathway could prevent or reverse peripheral neuropathy
Researchers at University of California San Diego School of Medicine, with colleagues at the National Institute of Diabetes and Digestive and Kidney Diseases, the University of Manitoba and St. Boniface Hospital Albrechtsen Research Centre in Canada, have identified a molecular signaling pathway that, when blocked, promotes sensory neuron growth and prevents or reverses peripheral neuropathy in cell and rodent models of type 1 and 2 diabetes, chemotherapy-induced neuropathy and HIV.
Alexion submits Soliris marketing applications to FDA, EMA for aHUS treatment
Alexion Pharmaceuticals, Inc. announced today that the company has submitted marketing applications to the U.S. Food and Drug Administration and the European Medicines Agency for Soliris as a treatment for patients with atypical Hemolytic Uremic Syndrome.
› Verified 6 days ago